In the past years numerous studies have demonstrated neuroprotection by small molecule HDAC inhibitors, broadly modulating all HDAC enzymes, in various human disease models, including Huntington’s disease (HD) [3], [4], [5]. Here, HDAC9 is linked to juvenile Huntington disease.